Flex Pharma plans to price its initial public offering of common stock

Company to sell stock through bookrunners Jefferies and Piper Jaffray

By Devika Patel

Knoxville, Tenn., Dec. 29 – Flex Pharma, Inc. will conduct an initial public sale of common stock with a 30-day greenshoe, according to a Form S-1 filed Monday with the Securities and Exchange Commission.

Jefferies and Piper Jaffray are the bookrunning managers, JMP Securities is the lead manager and Cantor Fitzgerald & Co. and Roth Capital Partners are the co-managers.

Proceeds will be used for research and development, sales and marketing, working capital and general corporate purposes.

The biotechnology company is based in Boston. The company’s expects its shares will trade on the Nasdaq under the symbol “FLKS.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.